Showing 8 of 8 recruiting trials for “myeloidlymphoid-neoplasm-associated-with-jak2-rearrangement”
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
🏥 Center for International Blood and Marrow Transplant Research📍 13 sites📅 Started Jul 2025View details ↗
RecruitingNCT06895538 ↗
Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy
Mosaic Trial for Stem Cell Transplant Recipients
Early Integration of Palliative and Supportive Care in Cellular Therapy
RecruitingNCT04014374 ↗
Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
👨⚕️ Elizabeth Krakow, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Feb 2018View details ↗
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
👨⚕️ Christian Capitini, MD, University of Wisconsin, Madison📍 1 site📅 Started Feb 2016View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →